4//SEC Filing
Mountain Berg Ltd 4
Accession 0000899243-18-020447
CIK 0001434418other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 8:04 PM ET
Size
11.7 KB
Accession
0000899243-18-020447
Insider Transaction Report
Form 4
Mountain Berg Ltd
10% Owner
Transactions
- Conversion
Series F Preferred Stock
2018-07-23−750,000→ 0 total→ Common Stock (68,127 underlying) - Conversion
Series E Preferred Stock
2018-07-23−444,444→ 0 total→ Common Stock (51,905 underlying) - Conversion
Common Stock
2018-07-23+174,926→ 174,926 total - Conversion
Series E-1 Preferred Stock
2018-07-23−604,338→ 0 total→ Common Stock (54,894 underlying)
Footnotes (1)
- [F1]On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001746350
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 8:04 PM ET
- Size
- 11.7 KB